Romaniuk Aleksandra, Paszel-Jaworska Anna, Totoń Ewa, Lisiak Natalia, Hołysz Hanna, Królak Anna, Grodecka-Gazdecka Sylwia, Rubiś Błażej
Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, 49 Przybyszewskiego St., 60-355, Poznań, Poland.
Department of Oncology, Poznan University of Medical Sciences, Poznań, Poland.
Mol Biol Rep. 2019 Feb;46(1):1401-1411. doi: 10.1007/s11033-018-4496-x. Epub 2018 Nov 17.
Telomerase is perceived as an immortality enzyme that enables passing the Hayflick limit. Its main function is telomere restoration but only in a limited group of cells, including cancer cells. Since it is found in a vast majority of cancer cells, it became a natural target for cancer therapy. However, it has much more functions than just altering the metabolism of telomeres-it also reveals numerous so-called non-canonical functions. Thus, a question arises whether it is always beneficial to turn it off when planning a cancer strategy and considering potential side effects? The purpose of this review is to discuss some of the recent discoveries about telomere-independent functions of telomerase in the context of cancer therapy and potential side effects.
端粒酶被视为一种能突破海弗利克极限的永生酶。它的主要功能是端粒修复,但仅在包括癌细胞在内的有限细胞群体中发挥作用。由于在绝大多数癌细胞中都能发现它,它成为了癌症治疗的天然靶点。然而,它的功能远不止改变端粒的代谢——它还展现出许多所谓的非经典功能。因此,在制定癌症治疗策略并考虑潜在副作用时,关闭端粒酶是否总是有益就成了一个问题。本综述的目的是在癌症治疗和潜在副作用的背景下,讨论一些关于端粒酶非端粒依赖性功能的最新发现。